ArticleBritish journal of clinical pharmacology2011
The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene.
Patricia McGettigan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.